-
Archives of Sexual Behavior Nov 2016This study explored the role of psychological trait factors in sexual desire and sexual activity. In particular, it investigated how these factors may contribute to...
This study explored the role of psychological trait factors in sexual desire and sexual activity. In particular, it investigated how these factors may contribute to maintaining a balance between motivational aspects and self-control abilities, as both have been considered important in relation to adaptive sexuality. Moreover, the study explored the relationship between sexual desire, activity, and satisfaction. Participants completed questionnaires assessing sexual desire (dyadic, solitary), sexual activity (with a partner, alone), sexual satisfaction, approach and avoidance motivation, attachment, self-control, sensation seeking, and mindfulness. Cluster analyses, based on participants' level of sexual desire and sexual activity, highlighted three distinct profiles for each gender related to different types of psychological functioning: (a) participants with high dyadic sexual desire and activity were the most sexually satisfied, showed optimal psychological functioning, and were characterized by a balance between motivational tendencies to seek positive rewards and self-control abilities (high approach motivation, secure attachment, high self-control, high mindfulness); (b) participants with high dyadic and solitary sexual desire and activity were moderately satisfied and showed a type of psychological functioning predominantly characterized by impulsivity (an overly high motivation to obtain rewards in women, and low self-control in men); (c) participants with low dyadic sexual desire and activity were the least sexually satisfied and were characterized by high motivation to avoid negative consequences and low self-control (high avoidance motivation, insecure attachment, and poor mindfulness). These results shed further light on how fundamental psychological factors contribute to explain the individual variability in sexual desire, activity, and satisfaction.
Topics: Adult; Cluster Analysis; Female; Humans; Libido; Male; Mindfulness; Motivation; Orgasm; Personal Satisfaction; Self-Control; Sex Factors; Sexual Behavior; Sexual Partners; Sexuality
PubMed: 25787208
DOI: 10.1007/s10508-014-0467-z -
Ugeskrift For Laeger Apr 2021Sexual behaviour is a normal and healthy part of life. However, some individuals report excessive sexual appetite and/or an inability to control sexual behaviour. The... (Review)
Review
Sexual behaviour is a normal and healthy part of life. However, some individuals report excessive sexual appetite and/or an inability to control sexual behaviour. The literature has conceptualised this behaviour as hypersexuality (HS). The aim of this review is to address the challenges associated with diagnosing HS reliably and the lack of empirical evidence on treatment of HS. Further research is required in order to define when or if excessive sexual behaviour is a clinical disorder or symptomatic of either a medical or psychiatric disorder and how this condition should be treated effectively.
Topics: Compulsive Behavior; Humans; Libido; Paraphilic Disorders; Sexual Behavior
PubMed: 33913428
DOI: No ID Found -
CNS Neuroscience & Therapeutics 2008We sought to determine whether maca, a Peruvian plant, is effective for selective-serotonin reuptake inhibitor (SSRI)-induced sexual dysfunction. We conducted a... (Comparative Study)
Comparative Study Randomized Controlled Trial
We sought to determine whether maca, a Peruvian plant, is effective for selective-serotonin reuptake inhibitor (SSRI)-induced sexual dysfunction. We conducted a double-blind, randomized, parallel group dose-finding pilot study comparing a low-dose (1.5 g/day) to a high-dose (3.0 g/day) maca regimen in 20 remitted depressed outpatients (mean age 36+/-13 years; 17 women) with SSRI-induced sexual dysfunction. The Arizona Sexual Experience Scale (ASEX) and the Massachusetts General Hospital Sexual Function Questionnaire (MGH-SFQ) were used to measure sexual dysfunction. Ten subjects completed the study, and 16 subjects (9 on 3.0 g/day; 7 on 1.5 g/day) were eligible for intent-to-treat (ITT) analyses on the basis of having had at least one postbaseline visit. ITT subjects on 3.0 g/day maca had a significant improvement in ASEX (from 22.8+/-3.8 to 16.9+/-6.2; z=-2.20, P=0.028) and in MGH-SFQ scores (from 24.1+/-1.9 to 17.0+/-5.7; z=-2.39, P=0.017), but subjects on 1.5 g/day maca did not. Libido improved significantly (P<0.05) for the ITT and completer groups based on ASEX item #1, but not by dosing groups. Maca was well tolerated. Maca root may alleviate SSRI-induced sexual dysfunction, and there may be a dose-related effect. Maca may also have a beneficial effect on libido.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lepidium; Libido; Male; Middle Aged; Phytotherapy; Pilot Projects; Plant Extracts; Plant Roots; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological
PubMed: 18801111
DOI: 10.1111/j.1755-5949.2008.00052.x -
American Family Physician Sep 2005For centuries, chasteberry has been used to treat many hormone-related gynecologic conditions. The current literature supports the use of chasteberry for cyclical breast... (Review)
Review
For centuries, chasteberry has been used to treat many hormone-related gynecologic conditions. The current literature supports the use of chasteberry for cyclical breast discomfort and premenstrual syndrome; data on its use for menstrual irregularities and fertility disorders are weak. Its traditional use as a galactagogue (i.e., a substance that enhances breast milk production) is not well supported in the literature and should be discouraged. There are no clinical data to support the use of chasteberry for reducing sexual desire, which has been a traditional application. Chasteberry is well tolerated; reported adverse effects are minor and may include gastrointestinal complaints, dizziness, and dry mouth. No herb-drug interactions have been reported, but caution is advised for its concomitant use with dopamine agonists or antagonists. Optimal standardization and dosing recommendations await clarification in clinical studies.
Topics: Female; Humans; Infertility, Female; Lactation; Libido; Menstruation Disturbances; Phytotherapy; Plant Extracts; Vitex
PubMed: 16156340
DOI: No ID Found -
Reviews in Endocrine & Metabolic... Dec 2022Sexual function, and testosterone (T) levels, progressively decline in aging men. Associated morbidities and metabolic disorders can accelerate the phenomenon. The... (Review)
Review
Sexual function, and testosterone (T) levels, progressively decline in aging men. Associated morbidities and metabolic disorders can accelerate the phenomenon. The specific contribution of low T to sexual function impairment in aging men has still not been completely clarified. Similarly, the role of T replacement therapy (TRT), as well as the combination of TRT with phosphodiesterase type 5 inhibitors (PDE5i) for patients with erectile dysfunction (ED), is still conflicting. Here we aim to summarize and critically discuss all available data supporting the contribution of low T to sexual impairment observed with aging as well as the possible role of TRT. Available data on men with sexual dysfunction show that reduced sexual desire is the most important correlate of male hypogonadism. Conversely, aging and associated morbidities substantially attenuate the relationship between ED and T. TRT is effective in improving sexual function in middle-aged and older subjects but its role is small and extremely variable. Lifestyle interventions can result in similar outcomes to those of TRT. In conclusion, it is our opinion that PDE5i along with lifestyle measures should be considered the first approach for treating ED even in subjects with milder T deficiency. When these interventions fail or are difficult to apply, TRT should be considered.
Topics: Middle Aged; Humans; Male; Aged; Testosterone; Hypogonadism; Erectile Dysfunction; Libido; Sexual Dysfunction, Physiological
PubMed: 35999483
DOI: 10.1007/s11154-022-09748-3 -
American Family Physician Aug 2000Decreased libido disproportionately affects patients with depression. The relationship between depression and decreased libido may be blurred, but treating one condition... (Review)
Review
Decreased libido disproportionately affects patients with depression. The relationship between depression and decreased libido may be blurred, but treating one condition frequently improves the other. Medications used to treat depression may decrease libido and sexual function. Frequently, patients do not volunteer problems related to sexuality, and physicians rarely ask about such problems. Asking a depressed patient about libido and sexual function and tailoring treatment to minimize adverse effects on sexual function can significantly increase treatment compliance and improve the quality of the patient's life.
Topics: Algorithms; Antidepressive Agents; Decision Trees; Depression; Female; Humans; Libido; Male; Medical History Taking; Patient Compliance; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological
PubMed: 10969857
DOI: No ID Found -
Current Opinion in Urology Nov 2017Erectile dysfunction and decreased libido are common complaints in the older male population. Recent studies have elucidated the role testosterone therapy (TTh) can play... (Review)
Review
PURPOSE OF REVIEW
Erectile dysfunction and decreased libido are common complaints in the older male population. Recent studies have elucidated the role testosterone therapy (TTh) can play in men with low testosterone levels. The aim of this review is to provide an overview of these findings and the utility of TTh. We specifically examine the role of TTh on erectile function, coadministration with phosphodiesterase type 5 inhibitors, and libido.
RECENT FINDINGS
Recent publications suggest that TTh improves mild erectile dysfunction, though may be less useful in men with more severe erectile dysfunction. In men unresponsive to phosphodiesterase type 5 inhibitors and with mild erectile dysfunction, TTh can further improve erectile function. TTh has also shown consistent benefit in improving libido in men with low testosterone levels at baseline, with no additional improvements once testosterone levels are normalized.
SUMMARY
The available literature supports a role for TTh in men with low testosterone levels, erectile dysfunction, and low libido, with symptomatic improvement in these men.
Topics: Erectile Dysfunction; Humans; Hypogonadism; Libido; Male; Penile Erection; Testosterone
PubMed: 28816715
DOI: 10.1097/MOU.0000000000000442 -
International Journal of Impotence... Mar 2022During the early stages of the outbreak, insufficient attention was paid to the impact on sexual function, which is logical in the face of potentially harmful and fatal... (Review)
Review
During the early stages of the outbreak, insufficient attention was paid to the impact on sexual function, which is logical in the face of potentially harmful and fatal infections. It is well documented that any close contact (6 feet or 2 m) with an infected person can result in exposure to SARS-CoV-2 so while coronavirus disease: (COVID-19) may not be "sexually transmitted" (through semen or vaginal fluids) the risks of proximal exposure are great-whether the activity is engaged in is sexual or not. For the last 3-4 months, scientific studies have shown that a mild or severe coronavirus infection can lead to sexual complications and prolonged libido problems as well as erectile dysfunction. Besides, following some barrier gestures during "face-to-face" sexual intercourse can be challenging. This paper focuses on the construction and prefiguration of a new paradigm of sexuality that distinguishes and associates sexual relations that take place in the presence of a real partner and those that take place within the context of a range of digital environments qualified as "virtual" that can provide safe contexts for erotic imagination and intimacy while both communicating and maintaining arousal. Together, they offer a vehicle for fantasy and entertainment of sexual arousal towards private pleasure.
Topics: COVID-19; Erotica; Female; Humans; Libido; Male; SARS-CoV-2; Sexual Behavior
PubMed: 34815550
DOI: 10.1038/s41443-021-00494-9 -
American Family Physician Oct 2017Testosterone therapy is increasingly common in the United States, and many of these prescriptions are written by primary care physicians. There is conflicting evidence... (Review)
Review
Testosterone therapy is increasingly common in the United States, and many of these prescriptions are written by primary care physicians. There is conflicting evidence on the benefit of male testosterone therapy for age-related declines in testosterone. Physicians should not measure testosterone levels unless a patient has signs and symptoms of hypogonadism, such as loss of body hair, sexual dysfunction, hot flashes, or gynecomastia. Depressed mood, fatigue, decreased strength, and a decreased sense of vitality are less specific to male hypogonadism. Testosterone therapy should be initiated only after two morning total serum testosterone measurements show decreased levels, and all patients should be counseled on the potential risks and benefits before starting therapy. Potential benefits of therapy include increased libido, improved sexual function, improved mood and well-being, and increased muscle mass and bone density; however, there is little or mixed evidence confirming clinically significant benefits. The U.S. Food and Drug Administration warns that testosterone therapy may increase the risk of cardiovascular complications. Other possible risks include rising prostate-specific antigen levels, worsening lower urinary tract symptoms, polycythemia, and increased risk of venous thromboembolism. Patients receiving testosterone therapy should be monitored to ensure testosterone levels rise appropriately, clinical improvement occurs, and no complications develop. Testosterone therapy may also be used to treat hypoactive sexual desire disorder in postmenopausal women and to produce physical male sex characteristics in female-to-male transgender patients.
Topics: Adult; Androgens; Cardiovascular Diseases; Female; Health Status; Humans; Hypogonadism; Libido; Male; Middle Aged; Risk Factors; Sexual Dysfunction, Physiological; Testosterone; United States; Women's Health
PubMed: 29094914
DOI: No ID Found -
Poultry Science Dec 2021Low fertilization rate is the main reason to limit the development of artificial insemination (AI) technology in ducks. However, the libido of male livestock has been...
Low fertilization rate is the main reason to limit the development of artificial insemination (AI) technology in ducks. However, the libido of male livestock has been confirmed to be related to semen quality and fertilization rate, and we found that the libido of drakes was different. Thus, the research on the libido of drakes may be the key to further develop and apply AI technology. In this research, we established the first scoring standard for libido evaluation in drakes based on the performance of drakes during training period. Phenotypically, the body weight of high libido group was lighter than that of the other groups, while the weight of testis and epididymis in the high libido group was higher than that in the low libido group. Furthermore, we constructed the first expression profile of hypothalamus, pituitary, testis, and epididymis of drakes with high or low libido. There were 2, 1822, 214, and 892 differentially expressed genes (DEGs) in hypothalamus, pituitary, testis, and epididymis. The expression and sequence of Translocation Associated Membrane Protein 2 (TRAM2) were different in high and low libido drakes, indicating that it may be a candidate gene related to drake's libido. The estrogen, prolactin, and oxytocin signaling pathways were all activated in the pituitary of the low libido group. Meanwhile, the metabolic and oxidative phosphorylation pathways were enriched by DEGs in pituitary, testis and epididymis. Our research reveals that the difference in metabolic may cause changes in body weight of drakes, resulting in altered hormone levels and oxidative phosphorylation of gonad, which negatively affects libido and spermatogenesis in drakes. These results provide novel insights into the avian libido and will help better understand the underlying molecular mechanisms.
Topics: Animals; Chickens; Libido; Male; Phenotype; Semen Analysis; Testis
PubMed: 34700098
DOI: 10.1016/j.psj.2021.101503